Deborah Assayag

Years Active: 2020-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yet Hong Khor, Max Schulte, Kerri A Johannson, Veronica Marcoux, Jolene H Fisher, Deborah Assayag, Helene Manganas, Nasreen Khalil, Martin R J Kolb, Christopher J Ryerson, null null
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: A registry-based study. The European respiratory journal (2023)
Deborah Assayag, Nazia Chaudhuri
Pirfenidone in fibrotic hypersensitivity pneumonitis: is it ready for prime time? Thorax (2023)
Nathan Hambly, Mohammed Abdul Malik Farooqi, Anna Dvorkin-Gheva, Kathryn Donohoe, Kristopher Garlick, Ciaran Scallan, Sy Giin Chong, Sarah MacIsaac, Deborah Assayag, Kerri A Johannson, Charlene D Fell, Veronica Marcoux, Helene Manganas, Julie Morisset, Alessia Comes, Jolene H Fisher, Shane Shapera, Andrea S Gershon, Teresa To, Alyson W Wong, Mohsen Sadatsafavi, Pierce G Wilcox, Andrew J Halayko, Nasreen Khalil, P Gerard Cox, Luca Richeldi, Christopher J Ryerson, Martin R J Kolb
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. The European respiratory journal 60 (4) (2022)
Deborah Assayag, Julie Morisset, Kerri A Johannson, Athol U Wells, Simon L F Walsh
Patient gender bias on the diagnosis of idiopathic pulmonary fibrosis. Thorax 75 (5) (2020)

Deborah Assayag.css-eqlu8i{font-size:small;padding-left:4px;}